Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;73(1):204-218.
doi: 10.1002/hep.31558. Epub 2020 Dec 10.

Risk Prediction Models for Post-Operative Mortality in Patients With Cirrhosis

Affiliations

Risk Prediction Models for Post-Operative Mortality in Patients With Cirrhosis

Nadim Mahmud et al. Hepatology. 2021 Jan.

Abstract

Background and aims: Patients with cirrhosis are at increased risk of postoperative mortality. Currently available tools to predict postoperative risk are suboptimally calibrated and do not account for surgery type. Our objective was to use population-level data to derive and internally validate cirrhosis surgical risk models.

Approach and results: We conducted a retrospective cohort study using data from the Veterans Outcomes and Costs Associated with Liver Disease (VOCAL) cohort, which contains granular data on patients with cirrhosis from 128 U.S. medical centers, merged with the Veterans Affairs Surgical Quality Improvement Program (VASQIP) to identify surgical procedures. We categorized surgeries as abdominal wall, vascular, abdominal, cardiac, chest, or orthopedic and used multivariable logistic regression to model 30-, 90-, and 180-day postoperative mortality (VOCAL-Penn models). We compared model discrimination and calibration of VOCAL-Penn to the Mayo Risk Score (MRS), Model for End-Stage Liver Disease (MELD), Model for End-Stage Liver Disease-Sodium MELD-Na, and Child-Turcotte-Pugh (CTP) scores. We identified 4,712 surgical procedures in 3,785 patients with cirrhosis. The VOCAL-Penn models were derived and internally validated with excellent discrimination (30-day postoperative mortality C-statistic = 0.859; 95% confidence interval [CI], 0.809-0.909). Predictors included age, preoperative albumin, platelet count, bilirubin, surgery category, emergency indication, fatty liver disease, American Society of Anesthesiologists classification, and obesity. Model performance was superior to MELD, MELD-Na, CTP, and MRS at all time points (e.g., 30-day postoperative mortality C-statistic for MRS = 0.766; 95% CI, 0.676-0.855) in terms of discrimination and calibration.

Conclusions: The VOCAL-Penn models substantially improve postoperative mortality predictions in patients with cirrhosis. These models may be applied in practice to improve preoperative risk stratification and optimize patient selection for surgical procedures (www.vocalpennscore.com).

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors have no additional disclosures or conflicts as relevant to this manuscript.

Figures

Figure 1:
Figure 1:
Kaplan-Meier Analysis of the Association between (A) ASA Classification, (B) Surgery Category, (C) Non-alcoholic Fatty Liver Disease, and (D) Obesity on Post-operative Mortality Abbreviations: ASA = American Society of Anesthesiologists; NAFLD = non-alcoholic fatty liver disease; BMI = body mass index
Figure 2:
Figure 2:
Post-operative Mortality Calibration of the Mayo Score over Time at 30 Days (A) and 90 Days (B), and Sum of Differences between Predicted and Observed Mortality over Time at 30 Days (C) and 90 Days (D) Caption: * Overlaid histograms indicate the distribution of contributing data points
Figure 3:
Figure 3:
Receiver Operating Characteristic Curves for 30-Day Post-Operative Mortality in Derivation (A) and Validation Cohorts (B), with Associated Calibration Curves (C), and for 90-Day Post-Operative Mortality in Derivation (D) and Validation Cohorts (E), with Associated Calibration Curves (F)
Figure 4:
Figure 4:
Receiver Operating Characteristic Curves for 180-Day Post-Operative Mortality in Derivation (A) and Validation Cohorts (B), with Associated Calibration Curves (C)

Comment in

References

    1. Friedman LS. The risk of surgery in patients with liver disease. Hepatology 1999;29:1617–1623. - PubMed
    1. Goel NJ, Agarwal P, Mallela AN, et al. Liver disease is an independent predictor of poor 30-day outcomes following surgery for degenerative disease of the cervical spine. The Spine Journal 2019;19:448–460. - PubMed
    1. Johnson KM, Newman KL, Green PK, et al. Incidence and Risk Factors of Postoperative Mortality and Morbidity After Elective Versus Emergent Abdominal Surgery in a National Sample of 8193 Patients With Cirrhosis. Annals of surgery 2019. - PubMed
    1. Parikh ND, Marrero WJ, Wang J, et al. Projected increase in obesity and non-alcoholic-steatohepatitis–related liver transplantation waitlist additions in the United States. Hepatology 2019;70:487–495. - PubMed
    1. Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology 2018. - PMC - PubMed

Publication types